CSF2 and neoplasm: Talimogene laherparepvec (T-VEC), a herpes simplex virus type 1 (HSV-1) that encodes granulocyte-macrophage colony-stimulating factor (GM-CSF), was designed to enhance anti-tumor immune response in addition to direct oncolytic effect.4